Grail Publishes PATHFINDER 2 Presentation on Multi-Cancer Detection in Adults Aged 65 and Older
Bitget2026/10/27 23:51- Grail published a medical research presentation on PATHFINDER 2 results for its Galleri multi-cancer early detection test in adults aged 65 and older.
- The test detected 41.9% of cancers diagnosed within 12 months, with 99.44% specificity.
- Positive predictive value was 56.9%, with cancer confirmed in 116 of 204 participants testing positive.
- Adding Galleri to USPSTF grade A/B screening increased screen-detected cancers 9.9-fold, to 129 from 13.
- Among newly diagnosed primary cancers detected by Galleri, 69.3% were stage I-III; 84.3% of those received curative-intent treatment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
